Degradation Kinetics Study of Anastrozole in Different Conditions by Reverse-Phase High-Performance Liquid Chromatography and Confirmation of its Major Degradation Product by Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry
-
Published:2019-02-11
Issue:3
Volume:15
Page:217-223
-
ISSN:1573-4129
-
Container-title:Current Pharmaceutical Analysis
-
language:en
-
Short-container-title:CPA
Author:
Sun Linjia1, Sun Xiaoyang1, Chen Yu1, Wang Binjie1, Chen Xiaohui1
Affiliation:
1. Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
Abstract
Background:
Drug stability is essential in the process of drug production, storage, appliance,
and so on. Some drugs’ degradation products may even have a toxic side effect, which can result in
safety risks and economic losses. Therefore, it is very imperative to develop a suitable stability indicating
an analytical method for anastrozole which could be used for stability testing, routine and in-process
quality control analysis or other further studies.
Methods:
A reverse-phase high-performance liquid chromatography method was developed and validated
for the degradation kinetics study of anastrozole, a selective non-steroid third-generation aromatase
inhibitor, which would provide a basis for further studies on anastrozole. The degradation product
was confirmed by ultra-performance liquid chromatography with tandem mass spectrometry.
Results:
Results showed that the degradation behavior of anastrozole followed first-order kinetics in
different temperatures, pH values and oxidation conditions. It was suggested that the degradation behavior
of anastrozole was pH-dependent and it’s more stable at lower pH values.
Conclusion:
A high performance liquid chromatography method was established and used to determine
the residual concentration of anastrozole in this study. It was found that the degradation behavior of
anastrozole followed first-order kinetics at different temperatures, pH values and oxidation conditions.
According to the results, the degradation of anastrozole was found to be pH-dependent and it is more
unstable in alkaline conditions. The information of degradation kinetics will be useful for understanding
the chemical stability of anastrozole and provide a reference for the further preparation research and
clinical therapy of anastrozole.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmaceutical Science,Molecular Medicine,Biochemistry,Biophysics
Reference15 articles.
1. Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI. J Nat Cancer Inst, Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17.,, 2005, 97, 1262-, 2. Smith IE, Dowsett M. N Engl J Med, Aromatase inhibitors in breast cancer.,, 2004, 2, 149-150, 3. Nagaraj G, Ma C. Breast Cancer Res Treat, Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer.,, 2015, 150, 231-242, 4. Davies EL. Medicine, Breast cancer.,, 2016, 44, 42-46, 5. Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF. Lanc Oncol, Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.,, 2010, 11, 1135-1141,
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|